» Articles » PMID: 34069970

δ-Catenin Participates in EGF/AKT/p21 Signaling and Induces Prostate Cancer Cell Proliferation and Invasion

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jun 2
PMID 34069970
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer (PCa) is the second most leading cause of death in males. Our previous studies have demonstrated that δ-catenin plays an important role in prostate cancer progression. However, the molecular mechanism underlying the regulation of δ-catenin has not been fully explored yet. In the present study, we found that δ-catenin could induce phosphorylation of p21 and stabilize p21 in the cytoplasm, thus blocking its nuclear accumulation for the first time. We also found that δ-catenin could regulate the interaction between AKT and p21, leading to phosphorylation of p21 at Thr-145 residue. Finally, EGF was found to be a key factor upstream of AKT/δ-catenin/p21 for promoting proliferation and metastasis in prostate cancer. Our findings provide new insights into molecular controls of EGF and the development of potential therapeutics targeting δ-catenin to control prostate cancer progression.

Citing Articles

Relationship between δ-catenin expression and whole-brain small-world network in breast cancer patients before chemotherapy.

Xue M, Du W, Cao J, Jiang Y, Song D, Yu D Sci Rep. 2024; 14(1):31119.

PMID: 39730828 PMC: 11681013. DOI: 10.1038/s41598-024-82391-x.


δ-catenin promotes Twist1 stabilization in prostate cancer through ubiquitination modification.

Tang W, Wang W, Lee H, Zhou J, Yu X, Zhou Q Am J Cancer Res. 2024; 14(8):3773-3788.

PMID: 39267672 PMC: 11387878. DOI: 10.62347/ALJT8663.


Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides.

Song H, Hu Z, Zhang S, Yang L, Feng J, Lu L Clin Proteomics. 2024; 21(1):53.

PMID: 39138419 PMC: 11321143. DOI: 10.1186/s12014-024-09503-7.


[Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].

Gao Z, Lin J, Hong P, Hu Z, Dong J, Shi Q Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(4):727-738.

PMID: 38708507 PMC: 11073945. DOI: 10.12122/j.issn.1673-4254.2024.04.15.


An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer.

Wu Z, Wu Z, Zeng J, Liu Y, Wang Y, Li H Aging (Albany NY). 2024; 16(1):43-65.

PMID: 38206293 PMC: 10817364. DOI: 10.18632/aging.205280.


References
1.
He Y, Kim H, Ryu T, Kang Y, Kim J, Kim B . δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF. FEBS Lett. 2012; 587(2):193-9. DOI: 10.1016/j.febslet.2012.11.024. View

2.
Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A . Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology. 2004; 146(1):77-84. DOI: 10.1210/en.2004-0588. View

3.
Nascimento-Viana J, Alcantara-Hernandez R, Oliveira-Barros E, Castello Branco L, Feijo P, Romeiro L . The α1-adrenoceptor-mediated human hyperplastic prostate cells proliferation is impaired by EGF receptor inhibition. Life Sci. 2019; 239:117048. DOI: 10.1016/j.lfs.2019.117048. View

4.
Wang Y, Fisher J, Mathew R, Ou L, Otieno S, Sublet J . Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nat Chem Biol. 2011; 7(4):214-21. PMC: 3124363. DOI: 10.1038/nchembio.536. View

5.
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre M . The Global Burden of Cancer 2013. JAMA Oncol. 2015; 1(4):505-27. PMC: 4500822. DOI: 10.1001/jamaoncol.2015.0735. View